Novo Nordisk Inc Drug Patent Portfolio

Novo Nordisk Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Novo Nordisk Inc News

Novo Nordisk Adjusts Approach Amid Growing Competition in US Weight-Loss Medication Pricing

16 Feb, 2026

Novo Nordisk Undergoes Concurrent FDA Review and Legal Challenges Regarding Weight Loss Medications | The Swamp

14 Feb, 2026

The surge of weight-loss products: India approaching a trend of unrestricted dieting solutions

14 Feb, 2026

Natco Pharma Receives Approval for Generic Semaglutide Amid Ongoing Patent Dispute - Whalesbook

14 Feb, 2026

See More